The Worldwide Market for Prescription Dermatological Drugs.pdf
《The Worldwide Market for Prescription Dermatological Drugs.pdf》由会员分享,可在线阅读,更多相关《The Worldwide Market for Prescription Dermatological Drugs.pdf(373页珍藏版)》请在三一文库上搜索。
1、Worldwide Market for Dermatological Drugs Rures adquireret umbraculi, etiam tremulus matrimonii libere senesceret app April 2010 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f THE WORLDWIDE MARKET FO
2、R PRESCRIPTION DERMATOLOGICAL DRUGS 7TH EDITION A KALORAMA INFORMATION MARKET INTELLIGENCE REPORT The Worldwide Market for Prescription Dermatological Drugs has been prepared by Kalorama Information. We serve business and industrial clients worldwide with a complete line of information services and
3、research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action- oriented executive by providing a thorough presentation of essential data and concise analysis. Author: Mary Anne Crandall Publication Date: April 2010 38 East 29th Street New York, N
4、ew York 10016 http:/www.KaloramaI E-MAIL: KLI1399532 . Table of COntents ii Copyright 2008 Kalorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. TABLE OF CONTENTS EXECUTIVE SUMMARY .
5、1 Introduction. 1 Scope and Methodology 2 Size and Growth of the Market. 3 Issues and Trends Affecting Market. 6 Competitor Analysis. 7 INTRODUCTION9 Structure and Function of the Skin. 9 Epidermis 9 Dermis. 10 Subcutaneous Tissue. 10 Epidermal Appendages. 11 Functions of the Skin 12 Effects of Agin
6、g on the Skin. 13 Dermatological Conditions and Treatment 16 Pharmacokinetics 18 Drug Absorption. 18 Distribution. 19 Bioavailability. 20 Drug Delivery Methods 21 Demographics of Skin Disorders, Incidence, and Prevalence. 22 ISSUES AND TRENDS.25 Patient Compliance. 25 Cosmetic Dermatologists 26 Mela
7、noma Survival Rates Falter. 27 Phosphatidylglycerol and Psoriasis. 28 New Itch Gene Found 29 New Filler Options 29 Consumer Confusion 30 Genetic Link to Psoriasis 31 Biologic Dermatology 32 Rx-to-OTC Switches. 33 Cosmeceuticals 37 Antioxidants 38 Table of Contents iii Copyright 2008 Kalorama Informa
8、tion Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Polypeptides 40 Teledermatology 40 Reimbursement Issues 41 Accutane IPledge Program 42 Laser Therapy. 43 Narrowband Ultraviolet B . 44 Photodynam
9、ic Therapy 44 New Guidelines for UVT treatment of Psoriasis 45 PYCR1 Gene 45 New Dermal Filler. 46 Thermage. 47 BRAF Gene 47 Toilet Seat Dermatitis. 48 Combination Therapies 48 New Oral Medications and Research for Acne 49 Synthetic Lipids for Skin Healing . 49 Importance of Drug Delivery. 50 Indust
10、ry Consolidation. 51 PRESCRIPTION ANTIACNE AND ROSACEA DRUGS55 Description of Disorders. 55 Description of Products 57 Benzoyl Peroxide 58 Retinoids. 60 Antibiotics. 66 Oral Contraceptives 73 Research and Development 74 Market Size and Growth 78 Global Market. 78 Markets by Geographical Region. 82 T
11、he Future of the Market. 87 Competitive Analysis 87 PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS 91 Overview 91 Description of Products 92 Keratolytics. 92 Moisturizers 94 Retinoids. 95 Table of COntents iv Copyright 2008 Kalorama Information Reproduction without prior written permission, in any med
12、ia now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Sunscreens. 97 Other Agents. 99 Research and Development 108 Market Size and Growth 111 Global Market. 111 Markets by Geographical Region. 116 The Future of the Market. 120 Competitive Analysis 122 PRESCRIPT
13、ION DERMATITIS AND SEBORRHEA DRUGS125 Overview 125 Description of Products 126 Topical Corticosteroids. 126 Systemic Corticosteroids 130 Other Products 132 Research and Development 135 Market Size and Growth 138 Global Market by Type. 138 Markets by Geographical Region. 142 Future of the Market 147
14、Competitive Analysis 147 PRESCRIPTION ANTIFUNGAL DRUGS 149 Overview 149 Description of Products 150 Systemic Formulations 150 Topical Formulations 155 Research and Development 163 Market Size and Growth 165 Global Market by Type. 165 Markets by Geographical Region. 170 Future of the Market 175 Compe
15、titive Analysis 175 PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS.179 Overview 179 Description of Products 182 Antiandrogens. 182 Androgen Inhibitors 183 Oral Contraceptives 184 Table of Contents v Copyright 2008 Kalorama Information Reproduction without prior written permission, in any media now in
16、 existence or hereafter developed, in whole or in any part, is strictly prohibited. Other Treatments 184 Research and Development 185 Market Size and Growth 186 Global Market by Type. 186 Markets by Geographical Region. 190 Future of the Market 195 Competitive Analysis 196 PRESCRIPTION HYPERPIGMENTA
17、TION/MELASMA DRUGS.199 Overview 199 Description of Products 200 Market Size and Growth 205 Global Market. 205 Markets by Geographical Region. 210 The Future of the Market. 214 Competitive Analysis 214 PRESCRIPTION PSORIASIS DRUGS215 Overview 215 Description of Products 223 Topical Psoriasis Products
18、 224 Systemic Psoriasis Preparations 227 Light Therapy 231 Biologics. 232 Research and Development 236 Market Size and Growth 241 Global Market by Type. 241 Markets by Geographical Region. 245 Future of the Market 249 Competitive Analysis 249 PRESCRIPTION SKIN CANCER DRUGS .253 Overview 253 Nonmelan
19、oma Skin Cancers. 254 Malignant Melanoma 256 Description of Products 257 5-Fluorouracil . 257 Mechlorethamine/Nitrogen Mustard. 258 Carmustine/BCNU (Topical) 258 Vinblastine (Intralesional) and Others 259 Table of COntents vi Copyright 2008 Kalorama Information Reproduction without prior written per
20、mission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Research and Development 260 Market Size and Growth 265 Global Market. 265 Markets by Geographical Region. 266 The Future of the Market. 271 Competitive Analysis 271 MISCELLANEOUS SKIN DIS
21、ORDER DRUGSANTIVIRALS AND ANTIPARASITICS.273 Overview 273 Antivirals. 273 Antiparasitics 274 Description of Products 275 Topical Antivirals. 275 Antiparasitic Agents 276 Other Skin Related Products. 278 Research and Development 281 Market Size and Growth 284 Global Market. 284 Markets by Geographica
22、l Region 288 The Future of the Market. 292 Competitive Analysis 292 WORLD MARKET SUMMARY.293 Overview 293 Total Market Size and Forecast. 294 Market and Competitive Analysis. 300 CORPORATE PROFILES.303 Allergan Inc. 304 Bayer AG. 309 Bristol-Myers Squibb 310 Galderma S.A 312 GlaxoSmithKline Plc 314
23、Johnson in addition, blood vessels and nerves that supply the skin run through it. Subcutaneous tissue consists of loose connective tissue with collagen and elastin fibers. The anatomic distribution of subcutaneous tissue is a secondary sex characteristic and is Two: Introduction 11 Copyright 2008 K
24、alorama Information Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. also controlled by heredity, age and eating habits. This layer supports, nourishes, insulates, and cushions the skin. Epidermal Ap
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- The Worldwide Market for Prescription Dermatological Drugs
链接地址:https://www.31doc.com/p-3801004.html